Comments Regarding Conducting Remote Regulatory Assessments Questions and Answers, Draft Guidance for Industry

The Consumer Healthcare Products Association (CHPA), as the leading national trade association representing manufacturers and marketers of consumer healthcare products, including over-the-counter drugs and dietary supplements, and consumer medical devices, is dedicated to upholding the highest standards in providing safe and reliable consumer healthcare products. We appreciate this opportunity to respond to the Food and Drug Administration's (FDA) Draft Guidance for Industry, "Conducting Remote Regulatory Assessments Questions and Answers" (2024 Guidance), as published in the Federal Register on January 6, 2024.